Modulation of Glycemic, Lipid, and HepatorenalBiomarkers by Silymarin Supplementation inType 2 Diabetes Mellitus. The Review of Diabetic Studies , [S. l.], v. 21, n. 1, 2025. DOI: 10.1900/1z2dn188. Disponível em: https://diabeticstudies.org/index.php/RDS/article/view/406. Acesso em: 12 sep. 2025.